The commonalities among people in the study who developed long COVID suggest that the condition s cause is the same regardless of which variant led to the initial infection.
Over 15 million people in the United States, around 4.5% of the population, had received the updated COVID-19 shots by October 27, lagging behind last year s vaccinations.
The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.
Around 4 million Americans received the updated COVID-19 shots in September, even as some people have found it difficult to book vaccination appointments or find the vaccines at no cost.
The European Union is in talks with Moderna over a new supply deal for the company s COVID-19 vaccines amid concerns over a rise in infections in the region.